AVIEW LCS vs Imbio RV/LV Software

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AVIEW LCS

by Coreline Soft Co.

Imbio RV/LV Software

by Imbio

AI Verdict

AVIEW LCS provides a comprehensive AI solution for lung cancer screening, COPD assessment, and coronary artery calcification scoring from low-dose CT scans. In contrast, Imbio RV/LV Software specializes in automatically measuring right and left ventricular diameters from CTPA scans to calculate a ratio for pulmonary embolism risk stratification. While both are radiology AI tools with cardiac components, they focus on distinct diagnostic targets and types of CT scans.

Choose AVIEW LCS if…

Choose AVIEW LCS if your institution requires a comprehensive AI solution for integrated cardiopulmonary assessment and lung cancer screening. This tool is ideal for programs focused on detecting and analyzing lung nodules, quantifying emphysema, and assessing coronary artery calcification from a single low-dose CT scan, streamlining workflows and enhancing diagnostic accuracy across multiple conditions.

View AVIEW LCS →

Choose Imbio RV/LV Software if…

Choose Imbio RV/LV Software if your primary need is rapid and automated assessment of right and left ventricular diameters from CTPA scans. This tool is specifically designed to provide an RV/LV ratio for risk stratification in acute pulmonary conditions, such as pulmonary embolism, offering a fully automated workflow for quick insights into cardiac strain.

View Imbio RV/LV Software →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AVIEW LCS	Imbio RV/LV Software
Pricing	Contact for pricing	Unknown
Deployment	Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)	Cloud-based, Locally virtualized (virtual machine, Docker), or through partners like Aidoc, Blackford Analysis, and Philips Healthcare. [9, 27]
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools emphasize automated workflows and seamless integration with existing radiology systems like PACS/RIS, indicating a strong focus on user experience. Both also generate comprehensive reports and annotated images, which contribute to ease of use for clinicians by providing clear and actionable insights.

Clinical Value

AVIEW LCS

AVIEW LCS Plus offers a more comprehensive clinical assessment by integrating automated lung nodule detection and analysis, COPD assessment, and coronary artery calcification scoring from a single low-dose CT scan. This multi-faceted approach provides broader diagnostic insights and addresses multiple significant health concerns, enhancing overall patient management and screening programs.

Pricing & Value

Imbio RV/LV Software

Imbio RV/LV Software provides more transparency regarding its pricing model, stating it is subscription-based and dependent on the number of analyses or installations. AVIEW LCS requires direct contact for pricing, which offers less upfront clarity for potential customers.

Enterprise Readiness

Imbio RV/LV Software

Imbio RV/LV Software demonstrates slightly stronger enterprise readiness by explicitly mentioning third-party HIPAA compliance certification by Compliancy Group and a broader list of integration partners, including major radiology platforms like Nuance, Aidoc, and Siemens Syngo.via. Both offer flexible deployment options and necessary regulatory clearances, but Imbio's ecosystem appears more extensively validated and integrated.

Innovation

AVIEW LCS

AVIEW LCS demonstrates greater innovation by integrating fully automatic analysis for lung cancer, COPD, and coronary artery calcification from a single low-dose CT scan. This multi-disease assessment capability from one imaging study represents a significant advancement in comprehensive cardiopulmonary screening and diagnostic efficiency.

Support & Docs

Tie

The provided structured facts do not contain specific information regarding the level of customer support or documentation available for either AVIEW LCS or Imbio RV/LV Software. Without further details, it is not possible to determine a winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AVIEW LCS	Imbio RV/LV Software
Name	AVIEW LCS	Imbio RV/LV Software
Company	Coreline Soft Co.	Imbio
Tagline	AI-Powered Lung Cancer Screening & Cardiopulmonary Assessment	Transforming Medical Images into Life-Changing Insights with AI
Primary Use Case	AI-powered solution for the detection and analysis of lung nodules, lung cancer, COPD, and coronary artery calcification from a single low-dose CT scan.	AI-powered tool that automatically measures right and left ventricular diameters from CTPA scans to aid in risk stratification for pulmonary conditions.
Key Feature Example	Automated lung nodule detection and analysis, Lung-RADS classification and reporting, Coronary Artery Calcification (CAC) scoring.	Automated measurement of right and left ventricular diameters, Calculation and reporting of RV/LV ratio, Provides annotated images showing ventricular measurements.
Specialties	Cardiology, Oncology, Pulmonology, Radiology	Cardiology, Pulmonology, Radiology

Videos

Demos, reviews, and walkthroughs featuring AVIEW LCS and Imbio RV/LV Software.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the core clinical applications and specific diagnostic insights offered by each tool?

AVIEW LCS is an AI-powered solution for the detection and analysis of lung nodules, providing integrated analysis of lung cancer, COPD, and coronary artery calcification from a single low-dose CT scan. It offers automated nodule detection and analysis, Lung-RADS classification, nodule volume quantification, emphysema quantification (LAA index), and coronary artery calcification (CAC) scoring. Imbio RV/LV Software, on the other hand, is an AI-powered tool that automatically measures right and left ventricular diameters from CTPA scans, primarily to aid in risk stratification for pulmonary conditions like pulmonary embolism.

What types of CT scans are compatible with each software, and what specific measurements or classifications do they provide?

AVIEW LCS utilizes low-dose CT scans and provides measurements such as nodule volume, 3D segmentation, Lung-RADS classification, emphysema quantification (LAA index), and Agatston, volume, and mass CAC scores. Imbio RV/LV Software requires contrast-enhanced CTPA scans as input and delivers automated measurements of right and left ventricular diameters, along with the calculated RV/LV ratio.

What are the integration capabilities of each tool with existing hospital systems like PACS/RIS, and how do they support automated workflows?

AVIEW LCS offers integration with PACS/RIS and third-party platforms, supporting comprehensive, automated report generation and automated comparison of nodules in follow-up CT scans. Imbio RV/LV Software is DICOM compliant and integrates with standard reading environments (PACS), providing a fully automated workflow where no user intervention is required after scan completion, with outputs automatically sent to PACS.

What are the key differences in the reporting features and output formats generated by AVIEW LCS versus Imbio RV/LV Software?

AVIEW LCS generates comprehensive, automated reports, including Lung-RADS classification and nodule volume quantification, with output formats such as copy-paste to report, Encapsulated DICOM PDF, PDF, and SR. Imbio RV/LV Software provides annotated images showing ventricular measurements and generates summary PDF reports, with DICOM compliant input and output.